Cargando…

Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis

PURPOSE: Electric cardioversion has been successfully used in terminating symptomatic atrial fibrillation (AF). Nevertheless, largescale study about the acute cardiovascular events following electrical cardioversion of AF is lacking. This study was performed to evaluate the incidence, risk factors,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Dong Geum, Cho, Iksung, Hartaigh, Bríain ó, Mun, Hee-Sun, Lee, Hye-Young, Hwang, Eui Seock, Park, Jin-Kyu, Uhm, Jae-Sun, Pak, Hui-Nam, Lee, Moon-Hyoung, Joung, Boyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630042/ https://www.ncbi.nlm.nih.gov/pubmed/26446636 http://dx.doi.org/10.3349/ymj.2015.56.6.1552

Ejemplares similares

Efficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation
por: Son, Nguyen Khac Le, et al.
Publicado: (2020)

Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin
por: Shin, Dong Geum, et al.
Publicado: (2016)

Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
por: Kim, Kyu, et al.
Publicado: (2018)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Safety and Efficacy of Switching Anticoagulation to Aspirin Three Months after Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
por: Uhm, Jae-Sun, et al.
Publicado: (2014)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
por: Mentias, Amgad, et al.
Publicado: (2021)

Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
por: Yu, Hee Tae, et al.
Publicado: (2020)

Serological Predictors for the Recurrence of Atrial Fibrillation After Electrical Cardioversion
por: Kim, Sook Kyoung, et al.
Publicado: (2010)

Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter
por: Wall, Christopher, et al.
Publicado: (2019)

Retraction: Serological Predictors for the Recurrence of Atrial Fibrillation After Electrical Cardioversion
por: Kim, Sook Kyoung, et al.
Publicado: (2023)

Prolonged PR Interval Predicts Clinical Recurrence of Atrial Fibrillation After Catheter Ablation
por: Park, Junbeom, et al.
Publicado: (2014)

Which patients recur as atrial tachycardia rather than atrial fibrillation after catheter ablation of atrial fibrillation?
por: Yang, Pil-Sung, et al.
Publicado: (2017)

A Thin Left Atrial Antral Wall Around the Pulmonary Vein Reflects Structural Remodeling by Atrial Fibrillation and is Associated with Stroke
por: Park, Junbeom, et al.
Publicado: (2017)

Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation
por: Yu, Hee Tae, et al.
Publicado: (2019)

Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study
por: Lee, Hye Young, et al.
Publicado: (2017)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
por: Lucà, Fabiana, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic and Public Restrictions on Outcomes After Catheter Ablation of Atrial Fibrillation
por: Kim, Daehoon, et al.
Publicado: (2022)

Various triggers of phase 4 block
por: Uhm, Jae-Sun, et al.
Publicado: (2018)

Effectiveness and safety of single transseptal ablation for atrial fibrillation in real‐word practice
por: Park, Yoon Jung, et al.
Publicado: (2021)

Does Additional Electrogram‐Guided Ablation After Linear Ablation Reduce Recurrence After Catheter Ablation for Longstanding Persistent Atrial Fibrillation? A Prospective Randomized Study
por: Kim, Tae‐Hoon, et al.
Publicado: (2017)

The Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort Data
por: Lee, Hancheol, et al.
Publicado: (2017)

The safety and efficacy of vitamin K antagonist in atrial fibrillation patients with previous ulcer bleeding: Long-term results from a multicenter study
por: Lee, Seung-Jun, et al.
Publicado: (2016)

Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism Patients
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Challenging Achievement of Bidirectional Block After Linear Ablation Affects the Rhythm Outcome in Patients With Persistent Atrial Fibrillation
por: Kim, Tae‐Hoon, et al.
Publicado: (2016)

eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation
por: Shim, Jaemin, et al.
Publicado: (2015)

Clinical Significance of Additional Ablation of Atrial Premature Beats after Catheter Ablation for Atrial Fibrillation
por: Kim, In-Soo, et al.
Publicado: (2016)

Gender Difference in the Long-Term Clinical Implications of New-Onset Atrial Fibrillation after Coronary Artery Bypass Grafting
por: Lee, Seung-Hyun, et al.
Publicado: (2017)

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
por: Deuling, J. H. H., et al.
Publicado: (2011)

The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation
por: Shah, Hriday, et al.
Publicado: (2023)

Associations of Abdominal Obesity and New‐Onset Atrial Fibrillation in the General Population
por: Baek, Yong‐Soo, et al.
Publicado: (2017)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019)

Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?
por: Naydenov, Stefan, et al.
Publicado: (2021)

One-Year Change in the H(2)FPEF Score After Catheter Ablation of Atrial Fibrillation in Patients With a Normal Left Ventricular Systolic Function
por: Kim, Min, et al.
Publicado: (2021)

Electrical cardioversion
por: Sucu, Murat, et al.
Publicado: (2009)

Characteristics of Pulmonary Vein Enlargement in Non-Valvular Atrial Fibrillation Patients with Stroke
por: Lee, Jung Myung, et al.
Publicado: (2014)

Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation
por: Yu, Hee Tae, et al.
Publicado: (2020)

Risk Factors for Stiff Left Atrial Physiology 1 Year After Catheter Ablation of Atrial Fibrillation
por: Lee, Jae-Hyuk, et al.
Publicado: (2021)

Lower pulmonary vein-to-left atrium volume ratio predicts poor rhythm outcome after atrial fibrillation catheter ablation
por: Lee, Jae-Hyuk, et al.
Publicado: (2022)

Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs
por: Park, Yoon Jung, et al.
Publicado: (2023)

Extra-Pulmonary Vein Triggers at de novo and the Repeat Atrial Fibrillation Catheter Ablation
por: Kim, Daehoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_phh10sljnlef5icpkucqq0tvbs